Breaking satellite silence: human satellite II RNA expression in ovarian cancer von Ganesan, Shridar

Volltext

Understanding and overcoming resistance to PARP inhibitors in cancer therapy von Dias, Mariana Paes, Moser, Sarah C., Ganesan, Shridar, Jonkers, Jos

Volltext

Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment von Rojas, Veronica, Hirshfield, Kim M, Ganesan, Shridar, Rodriguez-Rodriguez, Lorna

Volltext

Accurate and reproducible invasive breast cancer detection in whole-slide images: A Deep Learning approach for quantifying tumor extent von Cruz-Roa, Angel, Gilmore, Hannah, Basavanhally, Ajay, Feldman, Michael, Ganesan, Shridar, Shih, Natalie N.C., Tomaszewski, John, González, Fabio A., Madabhushi, Anant

Volltext

Nuclear shape and orientation features from H&E images predict survival in early-stage estrogen receptor-positive breast cancers von Lu, Cheng, Romo-Bucheli, David, Wang, Xiangxue, Janowczyk, Andrew, Ganesan, Shridar, Gilmore, Hannah, Rimm, David, Madabhushi, Anant

Volltext

High-throughput adaptive sampling for whole-slide histopathology image analysis (HASHI) via convolutional neural networks: Application to invasive breast cancer detection von Cruz-Roa, Angel, Gilmore, Hannah, Basavanhally, Ajay, Feldman, Michael, Ganesan, Shridar, Shih, Natalie, Tomaszewski, John, Madabhushi, Anant, González, Fabio

Volltext

Precision Medicine Oncology: A Primer von Rodriguez-Rodriguez, Lorna, Ganasen, Shridar, Hirshfield, Kim M, Khiabanian, Hossein, Riedlinger, Gregory

Volltext

Genomic and Immunologic Correlates of Indoleamine 2,3-Dioxygenase Pathway Expression in Cancer von Panda, Anshuman, Ganesan, Shridar

Volltext

Mutational landscape of the essential autophagy gene BECN1 in human cancers von Laddha, Saurabh V, Ganesan, Shridar, Chan, Chang S, White, Eileen

Volltext

Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer von George, Mridula A., Qureshi, Sadaf, Omene, Coral, Toppmeyer, Deborah L., Ganesan, Shridar

Volltext

Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer von Mehnert, Janice M, Panda, Anshuman, Zhong, Hua, Hirshfield, Kim, Damare, Sherri, Lane, Katherine, Sokol, Levi, Stein, Mark N, Rodriguez-Rodriquez, Lorna, Kaufman, Howard L, Ali, Siraj, Ross, Jeffrey S, Pavlick, Dean C, Bhanot, Gyan, White, Eileen P, DiPaola, Robert S, Lovell, Ann, Cheng, Jonathan, Ganesan, Shridar

Volltext

Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance von Anantha, Rachel W, Simhadri, Srilatha, Foo, Tzeh Keong, Miao, Susanna, Liu, Jingmei, Shen, Zhiyuan, Ganesan, Shridar, Xia, Bing

Volltext

Quantitative nuclear histomorphometry predicts oncotype DX risk categories for early stage ER+ breast cancer von Whitney, Jon, Corredor, German, Janowczyk, Andrew, Ganesan, Shridar, Doyle, Scott, Tomaszewski, John, Feldman, Michael, Gilmore, Hannah, Madabhushi, Anant

Volltext

Pan-cancer Analysis of Homologous Recombination Repair-associated Gene Alterations and Genome-wide Loss-of-Heterozygosity Score von Westphalen, C Benedikt, Fine, Alexander D, André, Fabrice, Ganesan, Shridar, Heinemann, Volker, Rouleau, Etienne, Turnbull, Clare, Garcia Palacios, Luis, Lopez, Jorge-Antonio, Sokol, Ethan S, Mateo, Joaquin

Volltext

Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer von Panda, Anshuman, Mehnert, Janice M, Hirshfield, Kim M, Riedlinger, Greg, Damare, Sherri, Saunders, Tracie, Kane, Michael, Sokol, Levi, Stein, Mark N, Poplin, Elizabeth, Rodriguez-Rodriguez, Lorna, Silk, Ann W, Aisner, Joseph, Chan, Nancy, Malhotra, Jyoti, Frankel, Melissa, Kaufman, Howard L, Ali, Siraj, Ross, Jeffrey S, White, Eileen P, Bhanot, Gyan, Ganesan, Shridar

Volltext

All-FIT: allele-frequency-based imputation of tumor purity from high-depth sequencing data von Loh, Jui Wan, Guccione, Caitlin, Di Clemente, Frances, Riedlinger, Gregory, Ganesan, Shridar, Khiabanian, Hossein

Volltext

Immune Checkpoint Inhibitors in Triple Negative Breast Cancer: The Search for the Optimal Biomarker von Qureshi, Sadaf, Chan, Nancy, George, Mridula, Ganesan, Shridar, Toppmeyer, Deborah, Omene, Coral

Volltext

Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors von Jaspers, Janneke E, Kersbergen, Ariena, Boon, Ute, Sol, Wendy, van Deemter, Liesbeth, Zander, Serge A, Drost, Rinske, Wientjens, Ellen, Ji, Jiuping, Aly, Amal, Doroshow, James H, Cranston, Aaron, Martin, Niall M B, Lau, Alan, O'Connor, Mark J, Ganesan, Shridar, Borst, Piet, Jonkers, Jos, Rottenberg, Sven

Volltext

Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer von SILVER, Daniel P, RICHARDSON, Andrea L, FATIMA, Aquila, GELMAN, Rebecca S, RYAN, Paula D, TUNG, Nadine M, DE NICOLO, Arcangela, GANESAN, Shridar, MIRON, Alexander, COLIN, Christian, SGROI, Dennis C, ELLISEN, Leif W, EKLUND, Aron C, WINER, Eric P, GARBER, Judy E, WANG, Zhigang C, SZALLASI, Zoltan, QIYUAN LI, JUUL, Nicolai, LEONG, Chee-Onn, CALOGRIAS, Diana, BURAIMOH, Ayodele

Volltext

BMI1 Is Recruited to DNA Breaks and Contributes to DNA Damage-Induced H2A Ubiquitination and Repair von Ginjala, Vasudeva, Nacerddine, Karim, Kulkarni, Atul, Oza, Jay, Hill, Sarah J., Yao, Ming, Citterio, Elisabetta, van Lohuizen, Maarten, Ganesan, Shridar

Volltext